WallStSmart

Chime Financial, Inc. Class A Common Stock (CHYM)vsSalesforce.com Inc (CRM)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Salesforce.com Inc generates 1799% more annual revenue ($41.52B vs $2.19B). CRM leads profitability with a 18.0% profit margin vs -46.2%. CRM earns a higher WallStSmart Score of 63/100 (C+).

CHYM

Avoid

35

out of 100

Grade: F

Growth: 6.7Profit: 3.0Value: 5.0Quality: 6.5
Piotroski: 3/9Altman Z: -1.15

CRM

Buy

63

out of 100

Grade: C+

Growth: 6.7Profit: 7.0Value: 10.0Quality: 6.0
Piotroski: 5/9Altman Z: 1.83
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for CHYM.

CRMUndervalued (+34.2%)

Margin of Safety

+34.2%

Fair Value

$276.43

Current Price

$181.96

$94.47 discount

UndervaluedFair: $276.43Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CHYM2 strengths · Avg: 9.0/10
Debt/EquityHealth
0.1010/10

Conservative balance sheet, low leverage

Revenue GrowthGrowth
25.5%8/10

Revenue surging 25.5% year-over-year

CRM4 strengths · Avg: 8.5/10
Market CapQuality
$171.49B9/10

Large-cap with strong market position

Debt/EquityHealth
0.199/10

Conservative balance sheet, low leverage

Price/BookValuation
2.9x8/10

Reasonable price relative to book value

Free Cash FlowQuality
$5.32B8/10

Generating 5.3B in free cash flow

Areas to Watch

CHYM4 concerns · Avg: 2.3/10
Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Return on EquityProfitability
-85.5%2/10

ROE of -85.5% — below average capital efficiency

EPS GrowthGrowth
-20.4%2/10

Earnings declined 20.4%

Altman Z-ScoreHealth
-1.152/10

Distress zone — elevated risk

CRM1 concerns · Avg: 4.0/10
Altman Z-ScoreHealth
1.834/10

Grey zone — moderate risk

Comparative Analysis Report

WallStSmart Research

Bull Case : CHYM

The strongest argument for CHYM centers on Debt/Equity, Revenue Growth. Revenue growth of 25.5% demonstrates continued momentum.

Bull Case : CRM

The strongest argument for CRM centers on Market Cap, Debt/Equity, Price/Book. Profitability is solid with margins at 18.0% and operating margin at 19.2%. Revenue growth of 12.1% demonstrates continued momentum.

Bear Case : CHYM

The primary concerns for CHYM are Piotroski F-Score, Return on Equity, EPS Growth.

Bear Case : CRM

The primary concerns for CRM are Altman Z-Score.

Key Dynamics to Monitor

CHYM profiles as a growth stock while CRM is a mature play — different risk/reward profiles.

CHYM is growing revenue faster at 25.5% — sustainability is the question.

CRM generates stronger free cash flow (5.3B), providing more financial flexibility.

Monitor SOFTWARE - APPLICATION industry trends, competitive dynamics, and regulatory changes.

Bottom Line

CRM scores higher overall (63/100 vs 35/100), backed by strong 18.0% margins and 12.1% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Chime Financial, Inc. Class A Common Stock

TECHNOLOGY · SOFTWARE - APPLICATION · USA

Chime Financial, Inc., a financial technology company, provides digital consumer banking and payment solutions. The company is headquartered in San Francisco, California.

Salesforce.com Inc

TECHNOLOGY · SOFTWARE - APPLICATION · USA

Salesforce.com, Inc. is an American cloud-based software company headquartered in San Francisco, California. It provides customer relationship management (CRM) service and also provides a complementary suite of enterprise applications focused on customer service, marketing automation, analytics, and application development.

Visit Website →

Want to dig deeper into these stocks?